Our panels focus on high-priority medical areas such as oncology, cardiology, neurology, pediatrics, and reproductive health. By analyzing only the relevant sections of the genome, these tests provide cost-effective, rapid, and clinically actionable results that support doctors in making informed treatment decisions.